This site is intended for US health care professionals only.


This site is intended for US health care professionals only.


  • CNS stimulants (amphetamines and methylphenidate-containing products), including Vyvanse, have a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy.
Full Safety Information Below

Vyvanse is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in patients ages 6 and above, and for the treatment of moderate to severe binge eating disorder (B.E.D.) in adults. Vyvanse is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of Vyvanse for the treatment of obesity have not been established.

Stay Informed

Sign up for Shire’s program for health care professionals. You’ll receive regular eNewsletters with important information and news. These resources are specifically designed for health care professionals like you!

* Required fields.


    Shire US Inc. will not sell or provide your e-mail information to other parties without your permission. This information will not be used for any purpose other than what is explained in our Privacy Policy Statement, available by clicking on this link: Review Shire Privacy Policy Statement. This consent will be in effect until such time as you opt out of the program.


    All content of this Web site including text, images, graphics, sound files, and their arrangements, belongs to Shire and is protected by international copyrights laws. All other intellectual property rights are reserved. The content may not be copied for commercial use or distribution nor may these objects be downloaded, modified, or posted to other sites.

    This site is intended solely for US residents and is governed solely by US laws and government regulations. Please see our online privacy policy for more information. While Shire US Inc. makes reasonable efforts to include accurate, up-to-date information on the site, Shire US Inc. makes no warranties or representations as to its accuracy. Shire US Inc. assumes no liability for any errors or omissions in the content of the site.

    S43072  09/18S43072  09/18S43072  09/18

    You are about to leave

    Please be advised that Shire has no control over the content or presentation of the site you are about to view.

    Cancel Continue
    Scroll for additional Important Safety Info & see Full Prescribing Information.